The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
Nathan M. Kendsersky(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia)
Cited by 119
Related Papers
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571
RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
|Nature|2021|100
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2